News

Apply Filter View All

CTTI and FDA Workshop Will Explore How Best to Include Patient Perspectives in Clinical Trials

CTTI will convene a public workshop, "Enhancing the Incorporation of Patient Perspectives in Clinical Trials" in collaboration with the FDA on Mon., March 18, from 9:00 a.m. to 5:00 p.m. at the Tommy Douglas Conference Center in Silver Spring, Md.

 

The workshop will seek ideas for best practices and key considerations for enhancing the incorporation of patient perspectives on clinical trial access, design, conduct, and post-trial follow-up. It will also gather input from patients, caregivers, industry, academic researchers, and expert practitioners on the challenges and barriers to patient participation in clinical trials. CTTI and the FDA are especially interested in the perspectives of patients, caregivers, researchers, and others who have participated in clinical trials and are willing to share their experiences.

 

This workshop meets an FDA commitment that is part of the sixth authorization of the Prescription Drug User Fee Act (PDUFA VI). After the event, a published report on proceedings and recommendations from the workshop will be made publicly available.

 

Register for the workshop by March 11. Registration is free and based on space availability, with priority given to early registrants. If you are unable to attend the workshop in person, you can watch the live webcast.

 

Don’t miss this opportunity to make your voice heard and shape the future of clinical research!